Operating Expenses Summary of Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.'s latest annual operating expenses in 2023 was 111.97 Billion JPY , down -33.81% from previous year.
Santen Pharmaceutical Co., Ltd.'s latest quarterly operating expenses in 2024 Q1 was 29.61 Billion JPY , down -12.88% from previous quarter.
Santen Pharmaceutical Co., Ltd. reported a annual operating expenses of 169.17 Billion JPY in annual operating expenses 2022, up 40.16% from previous year.
Santen Pharmaceutical Co., Ltd. reported a annual operating expenses of 120.7 Billion JPY in annual operating expenses 2021, down -12.83% from previous year.
Santen Pharmaceutical Co., Ltd. reported a quarterly operating expenses of 33.82 Billion JPY for 2023 Q3, up 6.91% from previous quarter.
Santen Pharmaceutical Co., Ltd. reported a quarterly operating expenses of 31.63 Billion JPY for 2023 Q2, up 6.82% from previous quarter.

Annual Operating Expenses Chart of Santen Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual Operating Expenses of Santen Pharmaceutical Co., Ltd. (2023 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2023	111.97 Billion JPY	-33.81%
2022	169.17 Billion JPY	40.16%
2021	120.7 Billion JPY	-12.83%
2020	138.46 Billion JPY	22.33%
2019	113.18 Billion JPY	15.31%
2018	98.16 Billion JPY	-1.71%
2017	99.87 Billion JPY	8.97%
2016	91.65 Billion JPY	116.76%
2015	42.28 Billion JPY	-39.67%
2014	70.08 Billion JPY	10.99%
2013	63.14 Billion JPY	19.4%
2012	52.88 Billion JPY	1.12%
2011	52.29 Billion JPY	14.6%
2010	45.63 Billion JPY	-1.31%
2009	46.24 Billion JPY	-7.84%
2008	50.17 Billion JPY	7.88%
2007	46.51 Billion JPY	4.31%
2006	44.58 Billion JPY	4.01%
2005	42.86 Billion JPY	7.16%
2004	40 Billion JPY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	29.61 Billion JPY	-12.88%
2023 Q3	33.82 Billion JPY	6.91%
2023 Q2	31.63 Billion JPY	6.82%
2023 Q1	29.61 Billion JPY	-33.74%
2023 FY	111.97 Billion JPY	-33.81%
2023 Q4	33.98 Billion JPY	0.49%
2022 Q1	28.79 Billion JPY	-15.27%
2022 FY	169.17 Billion JPY	40.16%
2022 Q4	44.69 Billion JPY	37.73%
2022 Q3	32.45 Billion JPY	-48.69%
2022 Q2	63.24 Billion JPY	119.64%
2021 Q3	29.63 Billion JPY	5.15%
2021 Q1	28.52 Billion JPY	-52.33%
2021 Q2	28.18 Billion JPY	-1.22%
2021 Q4	33.98 Billion JPY	14.69%
2021 FY	120.7 Billion JPY	-12.83%
2020 Q1	24.8 Billion JPY	-27.39%
2020 Q4	59.84 Billion JPY	112.92%
2020 Q3	28.1 Billion JPY	9.34%
2020 Q2	25.7 Billion JPY	3.63%
2020 FY	138.46 Billion JPY	22.33%
2019 Q4	34.16 Billion JPY	23.94%
2019 Q3	27.56 Billion JPY	7.29%
2019 Q2	25.69 Billion JPY	-0.3%
2019 Q1	25.76 Billion JPY	-9.34%
2019 FY	113.18 Billion JPY	15.31%
2018 Q4	28.42 Billion JPY	29.25%
2018 FY	98.16 Billion JPY	-1.71%
2018 Q2	24.3 Billion JPY	3.65%
2018 Q1	23.44 Billion JPY	-14.8%
2018 Q3	21.99 Billion JPY	-9.51%
2017 Q2	24.45 Billion JPY	9.6%
2017 Q1	22.31 Billion JPY	-14.53%
2017 Q3	25.59 Billion JPY	4.65%
2017 Q4	27.51 Billion JPY	7.54%
2017 FY	99.87 Billion JPY	8.97%
2016 Q2	21.4 Billion JPY	2.91%
2016 Q4	26.1 Billion JPY	11.85%
2016 FY	91.65 Billion JPY	116.76%
2016 Q1	20.8 Billion JPY	-14.16%
2016 Q3	23.34 Billion JPY	9.04%
2015 Q4	24.23 Billion JPY	9.81%
2015 FY	42.28 Billion JPY	-39.67%
2015 Q1	19.3 Billion JPY	1.35%
2015 Q2	-23.32 Billion JPY	-220.79%
2015 Q3	22.06 Billion JPY	194.62%
2014 Q3	18.89 Billion JPY	8.4%
2014 Q4	19.05 Billion JPY	0.81%
2014 FY	70.08 Billion JPY	10.99%
2014 Q1	14.7 Billion JPY	-27.93%
2014 Q2	17.43 Billion JPY	18.54%
2013 FY	63.14 Billion JPY	19.4%
2013 Q1	12.99 Billion JPY	-12.1%
2013 Q2	14.64 Billion JPY	12.69%
2013 Q3	15.09 Billion JPY	3.06%
2013 Q4	20.4 Billion JPY	35.17%
2012 FY	52.88 Billion JPY	1.12%
2012 Q3	13.28 Billion JPY	6.91%
2012 Q2	12.42 Billion JPY	0.31%
2012 Q4	14.78 Billion JPY	11.31%
2012 Q1	12.38 Billion JPY	-17.59%
2011 Q1	11.43 Billion JPY	-3.33%
2011 FY	52.29 Billion JPY	14.6%
2011 Q2	13.01 Billion JPY	13.83%
2011 Q3	12.81 Billion JPY	-1.54%
2011 Q4	15.03 Billion JPY	17.28%
2010 Q4	11.82 Billion JPY	3.39%
2010 FY	45.63 Billion JPY	-1.31%
2010 Q1	11.03 Billion JPY	-10.4%
2010 Q3	11.44 Billion JPY	0.97%
2010 Q2	11.33 Billion JPY	2.69%
2009 Q4	12.31 Billion JPY	6.06%
2009 Q2	11.91 Billion JPY	14.43%
2009 Q3	11.61 Billion JPY	-2.51%
2009 Q1	10.4 Billion JPY	-4.94%
2009 FY	46.24 Billion JPY	-7.84%
2008 Q2	11.73 Billion JPY	0.0%
2008 FY	50.17 Billion JPY	7.88%
2008 Q4	10.94 Billion JPY	-1.1%
2008 Q3	11.07 Billion JPY	-5.63%
2007 FY	46.51 Billion JPY	4.31%
2006 FY	44.58 Billion JPY	4.01%
2005 FY	42.86 Billion JPY	7.16%
2004 FY	40 Billion JPY	0.0%

Peer Operating Expenses Comparison of Santen Pharmaceutical Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Kyowa Kirin Co., Ltd.	224.77 Billion JPY	50.185%
Astellas Pharma Inc.	1034.29 Billion JPY	89.174%
Chugai Pharmaceutical Co., Ltd.	258.88 Billion JPY	56.748%
Ono Pharmaceutical Co., Ltd.	212.44 Billion JPY	47.293%
JCR Pharmaceuticals Co., Ltd.	23.72 Billion JPY	-372.062%
Daiichi Sankyo Company, Limited	974.77 Billion JPY	88.513%
Otsuka Holdings Co., Ltd.	1115.15 Billion JPY	89.959%
Perseus Proteomics Inc.	982.41 Million JPY	-11297.741%

Global Stocks Search

Santen Pharmaceutical Co., Ltd. (4536.T)

Operating Expenses Summary of Santen Pharmaceutical Co., Ltd.

Annual Operating Expenses Chart of Santen Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual Operating Expenses of Santen Pharmaceutical Co., Ltd. (2023 - 2004)

Peer Operating Expenses Comparison of Santen Pharmaceutical Co., Ltd.